x
Filter:
Filters applied
- Multimedia Library
- Review ArticleRemove Review Article filter
- American Journal of CardiologyRemove American Journal of Cardiology filter
Author
- Ako, Junya1
- Akram, Yasir1
- Andrade, Jason G1
- Atallah, Renée1
- Baker, Nevin C1
- Bennett, Matthew T1
- Biondi-Zoccai, Giuseppe1
- Bloom, Benjamin J1
- Callender, Tom1
- Cao, Jun1
- Carson, Kristin1
- Charpentier, Sandrine1
- Chen, Fang1
- Chenevier-Gobeaux, Camille1
- Cristol, Jean-Paul1
- D'Ascenzo, Fabrizio1
- Eggers, Kai M1
- Eisenberg, Mark J1
- Emdin, Connor A1
- Epstein, Stephen E1
- Escárcega, Ricardo O1
- Exner, Derek V1
- Faris, Peter1
- Filion, Kristian B1
- Fundytus, Adam1
Multimedia Library
9 Results
- Review
Review of Eligibility for Cardiac Resynchronization Therapy
American Journal of CardiologyVol. 116Issue 2p318–324Published online: April 18, 2015- Nathaniel M. Hawkins
- Matthew T. Bennett
- Jason G. Andrade
- Sean A. Virani
- Andrew D. Krahn
- Andrew Ignaszewski
- and others
Cited in Scopus: 2Cardiac resynchronization therapy (CRT) is underused. Recent guidelines have expanded indications for CRT to include less severe symptoms but now favor left bundle branch block morphology in patients with moderate QRS prolongation. The prevalence of CRT eligibility according to historical and current guidelines is uncertain. The aim of this review was to identify and synthesize all existing published research reporting the prevalence of CRT eligibility. A systematic review of electronic databases including MEDLINE, Embase, and the Cochrane Library was performed. - Review
Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure
American Journal of CardiologyVol. 116Issue 1p155–161Published online: April 9, 2015- Connor A. Emdin
- Tom Callender
- Jun Cao
- John J.V. McMurray
- Kazem Rahimi
Cited in Scopus: 29Renin-angiotensin-aldosterone system (RAAS) inhibition is 1 of the most effective strategies for the management of heart failure with reduced systolic function. However, trials that included patients with preserved systolic function have not shown a clear beneficial effect. Pooling evidence from several heart failure trials provides the opportunity to better assess the differential effects of RAAS inhibition across the continuum of systolic function. The authors searched MEDLINE for large-scale trials published from 1966 to March 2014 that compared RAAS inhibitors against placebos. - Review
Meta-Analysis of the Effects of Lifestyle Modifications on Coronary and Carotid Atherosclerotic Burden
American Journal of CardiologyVol. 115Issue 2p268–275Published online: October 31, 2014- Sunny Jhamnani
- Dhavalkumar Patel
- Layla Heimlich
- Fred King
- Brian Walitt
- Joseph Lindsay
Cited in Scopus: 23Lifestyle modifications are the crux of atherosclerotic disease management. The goal of this study was to determine the effectiveness of diet and exercise in decreasing coronary and carotid atherosclerotic burden. Randomized controlled trials examining the effects of intensive lifestyle measures on atherosclerotic progression in coronary and carotid arteries as measured by baseline and follow-up quantitative coronary angiogram and ultrasonographic carotid intimal-medial thickness (CIMT), respectively, were included. - Review
A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction
American Journal of CardiologyVol. 113Issue 9p1581–1591Published online: February 18, 2014- Michael J. Lipinski
- Ricardo O. Escárcega
- Fabrizio D'Ascenzo
- Marco A. Magalhães
- Nevin C. Baker
- Rebecca Torguson
- and others
Cited in Scopus: 106Multiple studies have evaluated copeptin, a surrogate for arginine vasopressin, in the diagnosis of acute myocardial infarction (AMI) with mixed results. A systematic review and collaborative meta-analysis were performed for diagnosis of AMI and assessment of prognosis in patients presenting to the emergency department with chest pain. MEDLINE/PubMed, Cochrane CENTRAL, and EMBASE were searched for studies assessing copeptin in such patients. Study investigators were contacted, and many provided previously unpublished data. - Review
Impact of Sugar-Sweetened Beverages on Blood Pressure
American Journal of CardiologyVol. 113Issue 9p1574–1580Published online: February 14, 2014- Aaqib Habib Malik
- Yasir Akram
- Suchith Shetty
- Senada Senda Malik
- Valentine Yanchou Njike
Cited in Scopus: 98The impact of sugar-sweetened beverages (SSBs) on blood pressure (BP) has been debated, with some evidence suggesting that their increased intake is related to higher risk of developing hypertension. We conducted a systematic review exploring the relation between consumption of SSB and BP. A comprehensive search in 5 electronic databases along with a bibliography search was performed. The keywords “sugar sweetened beverages,” “sugary drinks,” “added sugars,” “blood pressure,” and “hypertension” were indexed in all combinations. - Review
Meta-Analysis of Clinical Correlates of Acute Mortality in Takotsubo Cardiomyopathy
American Journal of CardiologyVol. 113Issue 8p1420–1428Published online: February 3, 2014- Kuljit Singh
- Kristin Carson
- Ranjit Shah
- Gagandeep Sawhney
- Balwinder Singh
- Ajay Parsaik
- and others
Cited in Scopus: 138The incidence and clinical correlates of acute in-hospital mortality of takotsubo cardiomyopathy (TTC) are not clear. We performed a systematic review and meta-analysis to consolidate the current evidence on acute mortality in TTC. We then assessed the impact of “secondary” TTC, male gender, advancing age, and catecholamine use on mortality. A comprehensive search of 4 major databases (EMBASE, Ovid MEDLINE, PubMed, and Google Scholar) was performed from their inception to the first week of July 2013. - Review
Meta-Analysis of Randomized Controlled Trials on the Risk of Bleeding With Dabigatran
American Journal of CardiologyVol. 113Issue 6p1066–1074Published online: December 26, 2013- Benjamin J. Bloom
- Kristian B. Filion
- Renée Atallah
- Mark J. Eisenberg
Cited in Scopus: 35Dabigatran is a univalent low-molecular-weight direct thrombin inhibitor that has been developed as an alternative to vitamin K antagonists (VKAs). However, uncertainty remains regarding dabigatran's safety profile with respect to bleeding. Our objective was to compare the risk of bleeding and all-cause mortality of dabigatran with that of VKAs in a systematic review and meta-analysis of randomized controlled trials (RCTs). We systematically searched MEDLINE, Embase, and the Cochrane Library of clinical trials to identify RCTs comparing the bleeding risk of dabigatran (150 mg twice daily) with that of VKAs. - Review
Meta-Analysis of the Effectiveness and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Versus Without Left Ventricular Systolic Dysfunction
American Journal of CardiologyVol. 106Issue 9p1284–1291Published in issue: November 01, 2010- Stephen B. Wilton
- Adam Fundytus
- William A. Ghali
- George D. Veenhuyzen
- F. Russell Quinn
- L. Brent Mitchell
- and others
Cited in Scopus: 95Catheter ablation is a promising therapy for atrial fibrillation (AF), but its utility in patients with left ventricular systolic dysfunction (LVSD) is uncertain. The objectives of this study were to perform a systematic review and meta-analysis of randomized and observational studies comparing the rates of recurrent AF, atrial tachycardia (AT), and complications after AF catheter ablation in those with versus without LVSD and to summarize the impact of catheter ablation on the left ventricular ejection fraction. - Review
Intravascular Ultrasound Imaging for Assessing Regression and Progression in Coronary Artery Disease
American Journal of CardiologyVol. 106Issue 12p1735–1746Published online: October 28, 2010- Hideaki Kaneda
- Junya Ako
- Mitsuyasu Terashima
Cited in Scopus: 16New imaging techniques have been used as surrogate markers of atherosclerotic burden to determine the effects of pharmacologic intervention. The aim of this study was to better determine potential utility and limitations of intravascular ultrasound (IVUS) imaging for assessing regression and progression in coronary artery disease. Medline was searched for randomized trials using IVUS for assessing regression and progression in coronary artery disease (through September 2009). A comparison of IVUS studies with large trials evaluating the same issue with clinical end points was performed.